Matrix Metalloproteinases in Rheumatoid Arthritis and Osteoarthritis: a State of the Art Review

Overview

Journal Reumatologia

Publisher Termedia

Specialty Rheumatology

Date 2023 Jul 31

PMID 37522140

Authors

Lukasz Pulik

Pawel Legosz

Gabriela Motyl

Affiliations

Soon will be listed here.

Abstract

Although the pathological mechanisms involved in osteoarthritis (OA) and rheumatoid arthritis (RA) are different, the onset and progression of both diseases are associated with several analogous clinical manifestations, inflammation, and immune mechanisms. In both diseases, cartilage destruction is mediated by matrix metalloproteinases (MMPs) synthesized by chondrocytes and synovium fibroblasts. This review aims to summarize recent articles regarding the role of MMPs in OA and RA, as well as the possible methods of targeting MMPs to alleviate the degradation processes taking part in OA and RA. The novel experimental MMP-targeted treatments in OA and RA are MMP inhibitors eg. 3-B2, taraxasterol, and naringin, while other treatments aim to silence miRNAs, lncRNAs, or transcription factors. Additionally, other recent MMP-related developments include gene polymorphism of MMPs, which have been linked to OA susceptibility, and the MMP-generated neoepitope of CRP, which could serve as a biomarker of OA progression.

Citing Articles

Temporal Transcriptomic Analysis of Periodontal Disease Progression and Its Molecular Links to Systemic Diseases.

Nantakeeratipat T, Fujihara C, Takedachi M Int J Mol Sci. 2025; 26(5).

PMID: 40076622 PMC: 11900451. DOI: 10.3390/ijms26051998.

Extracecellulr vesicles (EVs) microRNAs (miRNAs) derived from mesenchymal stem cells (MSCs) in osteoarthritis (OA); detailed role in pathogenesis and possible therapeutics.

Pakdaman Kolour S, Nematollahi S, Dehbozorgi M, Fattahi F, Movahed F, Esfandiari N Heliyon. 2025; 11(3):e42258.

PMID: 40007782 PMC: 11850152. DOI: 10.1016/j.heliyon.2025.e42258.

A versatile platform based on matrix metalloproteinase-sensitive peptides for novel diagnostic and therapeutic strategies in arthritis.

Li M, Deng T, Chen Q, Jiang S, Li H, Li J Bioact Mater. 2025; 47:100-120.

PMID: 39897588 PMC: 11787566. DOI: 10.1016/j.bioactmat.2025.01.011.

Integrative bioinformatics analysis reveals novel insights into osteoarthritis pathogenesis and diagnostic biomarkers.

Chen Q, Li X, Li P, Liu H, Zhang Q, He L BMC Musculoskelet Disord. 2024; 25(1):999.

PMID: 39639239 PMC: 11619307. DOI: 10.1186/s12891-024-08124-3.

Norisoboldine Reduces Arthritis Severity by Attenuating Inflammation, Oxidative Stress, and Extracellular Matrix Degradation in a Rat Model of Rheumatoid Arthritis.

Wang Y, Zhao X, Wang J, Zhu X J Inflamm Res. 2024; 17:8839-8852.

PMID: 39564548 PMC: 11575444. DOI: 10.2147/JIR.S476824.

References

Furer V, Greenberg J, Attur M, Abramson S, Pillinger M . The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol. 2010; 136(1):1-15. DOI: 10.1016/j.clim.2010.02.005. View

Boeters D, Burgers L, Sasso E, Huizinga T, van der Helm-van Mil A . ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation. Arthritis Res Ther. 2019; 21(1):121. PMC: 6518725. DOI: 10.1186/s13075-019-1902-2. View

Deligne C, Casulli S, Pigenet A, Bougault C, Campillo-Gimenez L, Nourissat G . Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients. Osteoarthritis Cartilage. 2015; 23(11):1843-52. DOI: 10.1016/j.joca.2014.12.007. View

Lepetsos P, Pampanos A, Kanavakis E, Tzetis M, Korres D, Papavassiliou A . Association of MMP-1 -1607 1G/2G (rs1799750) polymorphism with primary knee osteoarthritis in the Greek population. J Orthop Res. 2014; 32(9):1155-60. DOI: 10.1002/jor.22647. View

Alexander Jr L, McHorse G, Huebner J, Bay-Jensen A, Karsdal M, Kraus V . A matrix metalloproteinase-generated neoepitope of CRP can identify knee and multi-joint inflammation in osteoarthritis. Arthritis Res Ther. 2021; 23(1):226. PMC: 8407005. DOI: 10.1186/s13075-021-02610-y. View

Shlopov B, Lie W, Mainardi C, Cole A, Chubinskaya S, Hasty K . Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum. 1997; 40(11):2065-74. DOI: 10.1002/art.1780401120. View

Makris M, Alexandrou A, Papatsoutsos E, Malietzis G, Tsilimigras D, Guerron A . Ghrelin and Obesity: Identifying Gaps and Dispelling Myths. A Reappraisal. In Vivo. 2017; 31(6):1047-1050. PMC: 5756630. DOI: 10.21873/invivo.11168. View

Kamecka K, Rybarczyk-Szwajkowska A, Staszewska A, Engelseth P, Kozlowski R . Process of Posthospital Care Involving Telemedicine Solutions for Patients after Total Hip Arthroplasty. Int J Environ Res Public Health. 2021; 18(19). PMC: 8508342. DOI: 10.3390/ijerph181910135. View

Wilson C, Nishimuta J, Levenston M . Chondrocytes and meniscal fibrochondrocytes differentially process aggrecan during de novo extracellular matrix assembly. Tissue Eng Part A. 2009; 15(7):1513-22. PMC: 2810410. DOI: 10.1089/ten.tea.2008.0106. View

10.

Zeng R, Lu X, Lin J, Hu J, Rong Z, Xu W . Knockdown of FOXM1 attenuates inflammatory response in human osteoarthritis chondrocytes. Int Immunopharmacol. 2019; 68:74-80. DOI: 10.1016/j.intimp.2018.12.057. View

11.

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

12.

Araki Y, Mimura T . Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis. Int J Mol Sci. 2017; 18(5). PMC: 5454818. DOI: 10.3390/ijms18050905. View

13.

Omer Barlas I, Sezgin M, Erdal M, Sahin G, Ankarali H, Altintas Z . Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol Int. 2008; 29(4):383-8. DOI: 10.1007/s00296-008-0705-6. View

14.

Flannelly J, Chambers M, Dudhia J, Hembry R, Murphy G, Mason R . Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthritis Cartilage. 2002; 10(9):722-33. DOI: 10.1053/joca.2002.0818. View

15.

An Y, Wan G, Tao J, Cui M, Zhou Q, Hou W . Down-regulation of microRNA-203a suppresses IL-1β-induced inflammation and cartilage degradation in human chondrocytes through Smad3 signaling. Biosci Rep. 2020; 40(3). PMC: 7070148. DOI: 10.1042/BSR20192723. View

16.

Lei J, Fu Y, Zhuang Y, Zhang K, Lu D . LncRNA SNHG1 alleviates IL-1β-induced osteoarthritis by inhibiting miR-16-5p-mediated p38 MAPK and NF-κB signaling pathways. Biosci Rep. 2019; 39(9). PMC: 6732361. DOI: 10.1042/BSR20191523. View

17.

Shu S, Lin C, He H, Witwicki R, Tabassum D, Roberts J . Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016; 529(7586):413-417. PMC: 4854653. DOI: 10.1038/nature16508. View

18.

Nagase H, Visse R, Murphy G . Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006; 69(3):562-73. DOI: 10.1016/j.cardiores.2005.12.002. View

19.

Arpino V, Brock M, Gill S . The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015; 44-46:247-54. DOI: 10.1016/j.matbio.2015.03.005. View

20.

Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View